DUSTIN D JOHNSTON

Allopathic & Osteopathic Physicians|Internal Medicine DALTON, GA NPI 1578026530

General Payments — all program years on this page

$1,531.10

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 82
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $823.14 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $823.1440

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $44.163
2023 $663.8039
2024 $823.1440

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089510547 Currax Pharmaceuticals LLC $14.04 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096830719 Novo Nordisk Inc $22.56 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096887076 Novo Nordisk Inc $24.02 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097201713 Novo Nordisk Inc $22.47 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097238958 Novo Nordisk Inc $17.53 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097261971 Novo Nordisk Inc $15.95 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097349914 Novo Nordisk Inc $21.86 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097804205 Novo Nordisk Inc $24.83 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004998 ABBVIE INC. $31.25 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104005000 ABBVIE INC. $31.96 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104005002 ABBVIE INC. $15.62 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104005004 ABBVIE INC. $18.14 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104005006 ABBVIE INC. $31.51 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104005008 ABBVIE INC. $30.80 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104005010 ABBVIE INC. $25.26 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104642679 AstraZeneca Pharmaceuticals LP $22.34 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105520795 AstraZeneca Pharmaceuticals LP $15.10 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105648074 AstraZeneca Pharmaceuticals LP $13.25 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111610925 Amgen Inc. $15.54 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114440413 Exact Sciences Corporation $14.04 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117289743 Amgen Inc. $20.02 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118916649 Otsuka America Pharmaceutical, Inc. $16.96 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131120143 PFIZER INC. $22.78 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131221121 PFIZER INC. $13.51 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131238627 PFIZER INC. $14.43 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131966245 PFIZER INC. $18.09 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134964141 Lilly USA, LLC $16.15 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136153414 Lilly USA, LLC $13.19 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136154600 Lilly USA, LLC $23.16 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136162411 Lilly USA, LLC $14.02 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136163862 Lilly USA, LLC $16.51 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136163864 Lilly USA, LLC $14.39 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143251697 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.40 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144593144 Xeris Pharmaceuticals, Inc. $17.87 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148870251 Sumitomo Pharma America, Inc. $53.05 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148870253 Sumitomo Pharma America, Inc. $19.33 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151077658 Phathom Pharmaceuticals, Inc. $18.46 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153398377 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.32 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153595537 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.37 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153683131 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.06 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.